March 10, 2020 / 12:42 PM / in a month

BRIEF-Akebia Therapeutics Reports Q4 Revenue $69.6 Mln Versus $59.9 Mln

March 10 (Reuters) - Akebia Therapeutics Inc:

* AKEBIA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND HOSTS CONFERENCE CALL TO DISCUSS RECENT BUSINESS HIGHLIGHTS

* Q4 REVENUE ESTIMATE $93.1 MILLION — REFINITIV IBES DATA

* TOP-LINE DATA READOUTS OF GLOBAL PHASE 3 PROGRAM FOR VADADUSTAT ON TRACK FOR Q2 OF 2020 AND MID-2020

* QTRLY LOSS PER SHARE $0.79

* Q4 EARNINGS PER SHARE VIEW $-0.47 — REFINITIV IBES DATA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below